Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yazici, Z. A.
Right arrow Articles by Lindsey, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yazici, Z. A.
Right arrow Articles by Lindsey, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 13, No. 3, 349-357, March 2001
© 2001 Japanese Society for Immunology

Human monoclonal anti-endothelial cell IgG-derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro

Zihni Acar Yazici, Elena Raschi1,, Anjana Patel, Cinzia Testoni2,, M.Orietta Borghi2,, Anne Margaret Graham, Pier Luigi Meroni2, and Nigel Lindsey

Department of Biomedical Sciences, University of Bradford, Bradford BD7 1DP, UK
1 Department of Internal Medicine, IRCCS Ospedale Maggiore, Via Sforza 35, 20145 Milan, Italy
2 Department of Internal Medicine, IRCCS Istituto Auxologico Italiano, University of Milan, Via L. Ariosto 13, 20145 Milan, Italy.

Correspondence to: P. L. Meroni

Our objectives were to obtain monoclonal anti-endothelial cell antibodies (AECA) from systemic lupus erythematosus (SLE) patients, to characterize their antigen specificity, and their capability to induce a pro-inflammatory and pro-adhesive endothelial phenotype, and to investigate the mechanism of endothelial cell (EC) activation in vitro. Monoclonal IgG AECA were generated by hybridoma formation with human SLE B cells. Antigen specificity was characterized by immunoblotting with enriched cell membrane fractions, by cytofluorimetry and by cell solid-phase ELISA. Endothelial activation was evaluated by measuring increases in U937 cell adhesiveness, adhesion molecule (E-selectin and ICAM-1) expression and IL-6 production. In addition, mechanisms of endothelial activation were investigated by assessment of NF-{kappa}B by measuring the loss of its inhibitor I-{kappa}B. mAb E-3 bound live EC and recognized a 42 kDa EC membrane protein, it enhanced U937 adhesiveness, E-selectin and ICAM-1 expression and IL-6 production, and caused the loss of I-{kappa}B. We conclude this is the first in vitro demonstration that a human monoclonal AECA from a SLE patient reacts with a constitutive endothelial membrane antigen and induces a pro-inflammatory endothelial phenotype through NF-{kappa}B activation.

Keywords: adhesion molecules, anti-endothelial cell antibody, cytokines, systemic lupus erythematosus

Transmitting editor: I. Pecht


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
F. Montecucco and F. Mach
Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis
Rheumatology, January 1, 2009; 48(1): 11 - 22.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
E Rodriguez, J Guevara, A Paez, E Zapata, M. Collados, T. Fortoul, R Lopez-Marure, F Masso, and L. Montano
The altered expression of inflammation-related molecules and secretion of IL-6 and IL-8 by HUVEC from newborns with maternal inactive systemic lupus erythematosus is modified by estrogens
Lupus, December 1, 2008; 17(12): 1086 - 1095.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. O.S. Savage and J. M. Williams
Anti Endothelial Cell Antibodies in Vasculitis
J. Am. Soc. Nephrol., September 1, 2007; 18(9): 2424 - 2426.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Belizna, A Duijvestijn, M Hamidou, and J W Cohen Tervaert
Antiendothelial cell antibodies in vasculitis and connective tissue disease
Ann Rheum Dis, December 1, 2006; 65(12): 1545 - 1550.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-F. Lin, S.-C. Chiu, Y.-L. Hsiao, S.-W. Wan, H.-Y. Lei, A.-L. Shiau, H.-S. Liu, T.-M. Yeh, S.-H. Chen, C.-C. Liu, et al.
Expression of Cytokine, Chemokine, and Adhesion Molecules during Endothelial Cell Activation Induced by Antibodies against Dengue Virus Nonstructural Protein 1
J. Immunol., January 1, 2005; 174(1): 395 - 403.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
Y H Yang, H J Lai, C M Huang, L C Wang, Y T Lin, and B L Chiang
Sera from children with active Henoch-Schonlein purpura can enhance the production of interleukin 8 by human umbilical venous endothelial cells
Ann Rheum Dis, November 1, 2004; 63(11): 1511 - 1513.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
N J Abbott, L L. Mendonca, and D E. Dolman
The blood-brain barrier in systemic lupus erythematosus
Lupus, December 1, 2003; 12(12): 908 - 915.
[Abstract] [PDF]


Home page
CVIHome page
C. Drouet, M.-F. Nissou, D. Ponard, J. Arvieux, C. Dumestre-Perard, P. Gaudin, B. Imbert, C. Massot, and F. Sarrot-Reynauld
Detection of Antiendothelial Cell Antibodies by an Enzyme-Linked Immunosorbent Assay Using Antigens from Cell Lysate: Minimal Interference with Antinuclear Antibodies and Rheumatoid Factors
Clin. Vaccine Immunol., September 1, 2003; 10(5): 934 - 939.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
R L Bates, S J Payne, S L Drury, P N Nelson, D A Isenberg, J J Murphy, and G Frampton
The prevalence and clinical significance of autoantibodies to plasminogen activator inhibitor 1 in systemic lupus erythematosus
Lupus, August 1, 2003; 12(8): 617 - 622.
[Abstract] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. S. Segal, A. Bihorac, and M. Koc
Circulating endothelial cells: tea leaves for renal disease
Am J Physiol Renal Physiol, July 1, 2002; 283(1): F11 - F19.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.